CL2009001197A1 - Veterinary pharmaceutical composition containing the Chilean variety of infectious salmon anemia virus, protein markers and pharmaceutically acceptable excipients; procedure for obtaining the virus; use of the composition to prepare a vaccine for the prevention of the isa virus. - Google Patents

Veterinary pharmaceutical composition containing the Chilean variety of infectious salmon anemia virus, protein markers and pharmaceutically acceptable excipients; procedure for obtaining the virus; use of the composition to prepare a vaccine for the prevention of the isa virus.

Info

Publication number
CL2009001197A1
CL2009001197A1 CL2009001197A CL2009001197A CL2009001197A1 CL 2009001197 A1 CL2009001197 A1 CL 2009001197A1 CL 2009001197 A CL2009001197 A CL 2009001197A CL 2009001197 A CL2009001197 A CL 2009001197A CL 2009001197 A1 CL2009001197 A1 CL 2009001197A1
Authority
CL
Chile
Prior art keywords
virus
chilean
vaccine
prevention
prepare
Prior art date
Application number
CL2009001197A
Other languages
Spanish (es)
Inventor
Eduardo Pino Nunez Alejandro
Original Assignee
Farm En Aquacultura Veterinaria Fav S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farm En Aquacultura Veterinaria Fav S A filed Critical Farm En Aquacultura Veterinaria Fav S A
Priority to CL2009001197A priority Critical patent/CL2009001197A1/en
Priority to NO20092716A priority patent/NO20092716L/en
Publication of CL2009001197A1 publication Critical patent/CL2009001197A1/en
Priority to GB0915140A priority patent/GB2470238A/en
Priority to CA2678775A priority patent/CA2678775A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Composición farmacéutica veterinaria que contiene la variedad chilena del virus de la anemia infecciosa del salmón, marcadores proteicos y excipientes farmacéuticas aceptables; procedimiento de obtención del virus; uso de la composición para preparar una vacuna destinada a la prevención del virus isa.Veterinary pharmaceutical composition containing the Chilean variety of infectious salmon anemia virus, protein markers and acceptable pharmaceutical excipients; procedure for obtaining the virus; use of the composition to prepare a vaccine for the prevention of the isa virus.

CL2009001197A 2009-05-15 2009-05-15 Veterinary pharmaceutical composition containing the Chilean variety of infectious salmon anemia virus, protein markers and pharmaceutically acceptable excipients; procedure for obtaining the virus; use of the composition to prepare a vaccine for the prevention of the isa virus. CL2009001197A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CL2009001197A CL2009001197A1 (en) 2009-05-15 2009-05-15 Veterinary pharmaceutical composition containing the Chilean variety of infectious salmon anemia virus, protein markers and pharmaceutically acceptable excipients; procedure for obtaining the virus; use of the composition to prepare a vaccine for the prevention of the isa virus.
NO20092716A NO20092716L (en) 2009-05-15 2009-07-20 Protein markers suitable for distinguishing immunized and infected objects
GB0915140A GB2470238A (en) 2009-05-15 2009-08-28 Protein markers useful to differentiate immunized and infected specimens.
CA2678775A CA2678775A1 (en) 2009-05-15 2009-09-15 Protein markers useful to differentiate immunized and infected specimens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2009001197A CL2009001197A1 (en) 2009-05-15 2009-05-15 Veterinary pharmaceutical composition containing the Chilean variety of infectious salmon anemia virus, protein markers and pharmaceutically acceptable excipients; procedure for obtaining the virus; use of the composition to prepare a vaccine for the prevention of the isa virus.

Publications (1)

Publication Number Publication Date
CL2009001197A1 true CL2009001197A1 (en) 2009-08-21

Family

ID=41202926

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001197A CL2009001197A1 (en) 2009-05-15 2009-05-15 Veterinary pharmaceutical composition containing the Chilean variety of infectious salmon anemia virus, protein markers and pharmaceutically acceptable excipients; procedure for obtaining the virus; use of the composition to prepare a vaccine for the prevention of the isa virus.

Country Status (4)

Country Link
CA (1) CA2678775A1 (en)
CL (1) CL2009001197A1 (en)
GB (1) GB2470238A (en)
NO (1) NO20092716L (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI350310B (en) * 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
EP1685848A1 (en) * 2005-01-26 2006-08-02 Plant Research International B.V. Oral vaccines for fish
PL2181189T3 (en) * 2007-06-25 2012-11-30 South Dakota State Univ Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
US20090110698A1 (en) * 2007-10-31 2009-04-30 Newport Laboratories, Inc. Method of determining vaccine compliance

Also Published As

Publication number Publication date
GB0915140D0 (en) 2009-10-07
NO20092716L (en) 2010-11-16
GB2470238A (en) 2010-11-17
CA2678775A1 (en) 2010-11-15

Similar Documents

Publication Publication Date Title
CL2017000379A1 (en) Pyrrolopyrimidine compounds used as toll receptor agonists. 7 (tlr7)
AR115939A2 (en) COMPOSITION CONTAINING ULTRA-MICRONIZED PALMITOYL-ETHANOLAMIDE
NI201700101A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING N - (3, 5 - DIMETOXIPHENIL) - N'- (1-METHYLETHYL) - N - [3- (1-METHYL-1H-PIRAZOL-4-IL) QUINOXALINE-6-IL] ETHANE-1 , 2-DIAMINE
CY1122853T1 (en) SOLID FORMULATIONS OF LINACLOTIDE
AR104984A1 (en) SELECTIVE COMPOUNDS FOR PYY AND ITS USES
CL2018001199A1 (en) Comprimido de tres capas que comprende un compuesto de formula i, tenofovir alafenamida y emtricitabina; su uso en el tratamiento de una infeccion por vih.
ECSP13012467A (en) USE OF BINDERS TO MANUFACTURE STORAGE FORMULATIONS TO STORAGE
CL2012002355A1 (en) Compounds derived from 1,3,4,8-tetrahydro-2h-pyrido [1,2-a] pyrazine; pharmaceutical composition that includes them; pharmaceutical kit; and its use as hiv integrase inhibitors for the treatment of an infectious hiv disease.
GT201500020A (en) SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
CL2012001959A1 (en) Compounds derived from thiophene-2-carboxylic acid, flaviviridae virus inhibitors; pharmaceutical composition that includes them; and its use for the treatment of a viral infection by flaviviridae.
CL2011002830A1 (en) Compounds derived from haloalkyl heteroaryl benzamides; pharmaceutical composition use of the composition in the treatment of a viral infection, such as hepatitis b and c virus.
AR089578A1 (en) COMPOSITIONS, METHODS TO TREAT HEPATITIS C VIRUS AND PREPARATION PROCESS
CL2012001176A1 (en) Benzimidazole-imidazole derivative compounds, hepatitis c virus (hcv) inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; use in the prevention or treatment of hcv infection.
CL2013003229A1 (en) Hepatitis C virus (vhc) inhibitor compounds; pharmaceutical composition that includes them; and use in the treatment of a vhc infection.
CO6480995A2 (en) NEW PROTEIN CONSTRUCTIONS OF THE HUMAN PAILOMA VIRUS (HPV) AND ITS USE IN THE PREVENTION OF HPV DISEASE
CR20170314A (en) FORMULATION OF GLARGINE / LIXISENATIDA INSULIN FIXED RELATIONSHIP
CL2013001877A1 (en) Immunogenic composition comprising a modified live bovine viral diarrhea type 1b virus and an acceptable veterinary carrier; vaccine that includes it; and its use to prevent, treat, manage or relieve one or more symptoms of a disease caused by pestivirus.
DOP2016000254A (en) PHARMECEUTIC FORMULATIONS OF PAN-RAF QUINASE INHIBITOR, PROCEDURES FOR THEIR PREPARATION, AND METHODS OF USE.
AR094707A1 (en) COMPOUND OF QUINAZOLIN-4-AMINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE TREATMENT OF A DISEASE MEDIATED BY THE RIP2 KINASE
CL2016000300A1 (en) Therapeutic methods
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases
CL2015000848A1 (en) Use of a propylmethylphenol compound, or a composition comprising it, to produce a pharmaceutical and / or nutraceutical composition for the treatment and / or prophylaxis of infectious salmon anemia (isa) (divisional sol. No. 2654-12).
PE20150167A1 (en) (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL
CR20160495A (en) FREE COMPOSITIONS OF CELLS FOR THE RESTORATION OF CELLS AND METHODS FOR THE PREPARATION AND USE OF THE SAME
EA201991265A1 (en) MEDICINAL FORMS WITH DELAYED DELIVERY CONTAINING DIMETHYLFUMARATE